TRPH-395

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTRPH-395
Drug Alias NameTRPH395TRPH-395
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWD repeat-containing protein 5 inhibitors
TargetsWD repeat-containing protein 5
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTriphase Accelerator CorpOntario Institute For Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesOntario Institute For Cancer ResearchTriphase Accelerator CorpCelgene Corp
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A